Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Prevent Coronary Artery Disease Trial (PRECAD)
NCT06494501Phase 3Recruiting
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Sep 2024
- Primary completion
- Jun 2032
- Modality
- Antisense DNA, Conjugated siRNA, MicroRNA (miRNA)
- Countries
- 1
01
Overview
A Phase 3 trial of inclisiran in atherosclerosis, sponsored by Icahn School of Medicine at Mount Sinai. Started Sep 2024; status: recruiting.
02
Drugs
inclisiran
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT06494501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06494501.